Repare Therapeutics Inc reports results for the quarter ended in September - Earnings Summary

Repare Therapeutics

10/11/2021 14:06

* Repare Therapeutics Inc  RPTX.OQ  reported a quarterly
adjusted loss of 83 cents​​ per share for the quarter ended in
September. The mean expectation of eight analysts for the
quarter was for a loss of 71 cents per share.
* Revenue was $278.00 thousand​;  analysts expected $139.86
thousand. 
* Repare Therapeutics Inc's reported EPS for the quarter was a
loss of 83 cents​.
* The mean earnings estimate of analysts had fallen by
about 6.5% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Repare Therapeutics Inc shares had fallen by 0.1% this
quarter and lost 23.6% so far this year.
* The company reported a quarterly loss of $30.89 million.
* Wall Street's median 12-month price target for Repare
Therapeutics Inc is $47.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 9 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 10 at 02:06 p.m.
 ​All figures in US dollars unless otherwise stated